Effect of Letrozole on endometriosis-related pelvic pain.

To determine the role of Letrozole, an aromatase inhibitor, in the treatment of endometriotic pain.
In this prospective, randomized, controlled clinical trial in minimally invasive surgery research center, 51 women with pelvic endometriosis and endometriotic pain (dyspareunia, dysmenorrhea, pelvic pain) score of 5 or more (for at least one of these endometriotic pain), after laparoscopic diagnosis and conservative laparoscopic surgery were treated with either Letrozole plus OCP (n=25) or only OCP (n=26) for 4 months continuously.
Using VAS test, the score of dyspareunia, dysmenorrhea and pelvic pain 4 months after the laparoscopic surgery declined significantly in both groups but the difference between results of the two groups was not significant.
Both treatment modalities showed comparable effectiveness in the treatment of pains related to endometriosis and in comparison with OCP, Letrozole did not affect the outcome.
AuthorsFariba Almassinokiani, Alireza Almasi, Peyman Akbari, Mahboubeh Saberifard
JournalMedical journal of the Islamic Republic of Iran (Med J Islam Repub Iran) Vol. 28 Pg. 107 ( 2014) ISSN: 1016-1430 [Print] Iran
PMID25664308 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: